Company news

Goodrx Holdings, Inc. (NASDAQ:GDRX) news

Goodrx Holdings, Inc. news releases on 6ix. Latest, Sep 3, 2026: From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings…

Goodrx Holdings, Inc. (NASDAQ:GDRX) news

Press releases & updates

From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household

GoodRx Reports Second Quarter 2026 Results

GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call

GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs

GoodRx Reports First Quarter 2026 Results

GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients

GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call

GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price

GoodRx Expands Access to Eli Lilly and Company's New Oral GLP-1, Foundayo, and Zepbound KwikPen with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide

GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide

GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications

GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen®

GoodRx Reports Fourth Quarter and Full Year 2025 Results

GoodRx Expands Into Employer Market With Launch of “GoodRx Employer Direct”

GoodRx Powers Pricing for Leading Brand Medications on TrumpRx

GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale

60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership

GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

Surescripts and GoodRx Partner to Advance Patient Price Transparency

GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies

GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill

GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference

GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®

GoodRx Reports Third Quarter 2025 Results

GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment

GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call

GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings

GoodRx Launches Brand Medication Savings Program at National Retail Pharmacy

GoodRx Saddles Up With "The Savings Wrangler," a Bold New Brand Campaign to Tame the Wild West of Prescription Pricing

GoodRx Saddles Up With “The Savings Wrangler,” a Bold New Brand Campaign to Tame the Wild West of Prescription Pricing

GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month

GoodRx Reports Second Quarter 2025 Results

GoodRx Appoints Amazon Pharmacy Veteran Laura Jensen as President of Pharma Solutions

GoodRx Announces Date for Second Quarter 2025 Earnings Release and Conference Call

GoodRx Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment Barriers

GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing

GoodRx Open Sources Lifecycle to Support Innovation in Software Development Velocity and Developer Productivity

GoodRx to Launch Direct Contracting for Independent Community Pharmacies

GoodRx Reports First Quarter 2025 Results

GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call

GoodRx Introduces New E-commerce Experience for Retail Pharmacies

GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement

GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending

GoodRx Reports Fourth Quarter and Full Year 2024 Results

GoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats

GoodRx Appoints Christopher A. McGinnis as Chief Financial Officer

GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

Scott Wagner Joins GoodRx Board of Directors

GoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by Wildfires

GoodRx Unleashes “GoodRx for Pets,” Simplifying Access and Reducing Costs for Pet Medications